title: Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
authors: Junko
authors: J
authors: Ozao-Choy
authors: Marc L
authors: ML
authors: Friedman
authors: Amanda S
authors: AS
authors: Kim
authors: Ashely
authors: A
authors: Wachsman
authors: Edward M
authors: EM
authors: Wolin
authors: Run
authors: R
authors: Yu
authors: Nicholas N
authors: NN
authors: Nissen
authors: Steven D
authors: SD
authors: Colquhoun
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D004067:Digestive System Neoplasms / Q000473:pathology*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000473:pathology; D007680:Kidney Neoplasms / Q000473:pathology; D008113:Liver Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000532:radiotherapy* / Q000556:secondary*; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000097:blood / Q000000981:diagnostic imaging / Q000532:radiotherapy* / Q000556:secondary*; D010190:Pancreatic Neoplasms / Q000473:pathology; D011859:Radiography; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes / Q000008:administration & dosage*
chemical_list: D014408:Biomarkers, Tumor; D015021:Yttrium Radioisotopes